Sean Lee
Stock Analyst at HC Wainwright & Co.
(3.64)
# 716
Out of 4,829 analysts
81
Total ratings
32.5%
Success rate
11.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VSTM Verastem | Maintains: Buy | $10 → $14 | $7.17 | +95.26% | 14 | May 9, 2025 | |
| DWTX Dogwood Therapeutics | Upgrades: Buy | $10 | $4.56 | +119.30% | 1 | Apr 23, 2025 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $20 | $12.21 | +63.80% | 12 | Apr 14, 2025 | |
| CASI CASI Pharmaceuticals | Maintains: Buy | $6 → $4 | $1.89 | +112.16% | 8 | Apr 9, 2025 | |
| CTSO Cytosorbents | Reiterates: Neutral | $1 | $0.87 | +14.81% | 12 | Apr 3, 2025 | |
| MNPR Monopar Therapeutics | Reiterates: Buy | $40 | $39.42 | +1.47% | 10 | Apr 1, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $8 → $5.5 | $0.66 | +733.33% | 11 | Mar 28, 2025 | |
| CRVS Corvus Pharmaceuticals | Reiterates: Buy | $11 | $4.43 | +148.31% | 3 | Mar 26, 2025 | |
| MYO Myomo | Maintains: Buy | $7.5 → $9.5 | $3.20 | +196.88% | 5 | Mar 12, 2025 | |
| KZIA Kazia Therapeutics | Reiterates: Buy | $100 | $3.62 | +2,662.43% | 4 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.26 | +2,280.76% | 1 | Dec 5, 2022 |
Verastem
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $7.17
Upside: +95.26%
Dogwood Therapeutics
Apr 23, 2025
Upgrades: Buy
Price Target: $10
Current: $4.56
Upside: +119.30%
Alphatec Holdings
Apr 14, 2025
Reiterates: Buy
Price Target: $20
Current: $12.21
Upside: +63.80%
CASI Pharmaceuticals
Apr 9, 2025
Maintains: Buy
Price Target: $6 → $4
Current: $1.89
Upside: +112.16%
Cytosorbents
Apr 3, 2025
Reiterates: Neutral
Price Target: $1
Current: $0.87
Upside: +14.81%
Monopar Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $39.42
Upside: +1.47%
Plus Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $8 → $5.5
Current: $0.66
Upside: +733.33%
Corvus Pharmaceuticals
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $4.43
Upside: +148.31%
Myomo
Mar 12, 2025
Maintains: Buy
Price Target: $7.5 → $9.5
Current: $3.20
Upside: +196.88%
Kazia Therapeutics
Jul 12, 2024
Reiterates: Buy
Price Target: $100
Current: $3.62
Upside: +2,662.43%
Dec 5, 2022
Initiates: Buy
Price Target: $30
Current: $1.26
Upside: +2,280.76%